# A Phase I of SS109 in Hemophilia A or and B With Inhibitors

> **NCT05651061** · PHASE1 · COMPLETED · sponsor: **Jiangsu Gensciences lnc.** · enrollment: 27 (actual)

## Conditions studied

- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor
- Factor VII Deficiency

## Interventions

- **BIOLOGICAL:** SS109

## Key facts

- **NCT ID:** NCT05651061
- **Lead sponsor:** Jiangsu Gensciences lnc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-14
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-08-15
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05651061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05651061, "A Phase I of SS109 in Hemophilia A or and B With Inhibitors". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05651061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*